Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: A phase 2 consortium study
Jaime R. Merchan, Rui Qin, Henry Pitot, Joel Picus, Glenn Liu, Tom Fitch, William J. Maples, Patrick J. Flynn, Briant F. Fruth, Charles Erlichman
Dive into the research topics of 'Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: A phase 2 consortium study'. Together they form a unique fingerprint.